Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacogenetic study of hydrochlorothiazide and felodipine in Chinese patients with hypertension
ChiCTR-OCH-12002710Phase 4Completed
- Sponsor
- Pharmacogenetics Research Institute, Xiangya Hospital, Central South University
- Start
- Jan 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of hydrochlorothiazide and felodipine in hypertension (HTN) (2 arms), sponsored by Pharmacogenetics Research Institute, Xiangya Hospital, Central South University. Primary endpoints: Hypertension-related genes and Blood pressure. Started Jan 2009; status: completed.
02
Drugs
hydrochlorothiazidefelodipine
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on ChiCTR-OCH-12002710.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OCH-12002710.